Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15… [+1935 chars]
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug - CNBC
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
By:Chloe Taylor
Source:CNBC
Published:
Related News
Speculation Mounts Japan to Buy Yen, Perhaps With US Help - Bloomberg
Speculation mounted into the weekend that Japanese authorities could be preparing to enter currency markets in a bid to halt the yen’s slide, possibly with the rare assistance of the US.
Bloomberg•Carter Johnson
TikTok users freak out over app’s ‘immigration status’ collection — here’s what it means - TechCrunch
TikTok users are freaking out over a mention of "immigration status" data collection, but lawyers explain the disclosure is related to state privacy laws.
TechCrunch•Sarah Perez
Car crashes through glass doors of Delta check-in at DTW - detroitnews.com
Social media posts of a video showing a car inside the terminal and check-in area were circulating. Another video showed a man who was yelling being forcibly removed from the area of the crash.
The Detroit News•Jennifer Chambers